The purpose of this study is to assess the pharmacokinetic parameters for ABC and 3TC in
HIV-infected children younger than 18 years old with body weight ≥ 14 kgs.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
The HIV Netherlands Australia Thailand Research Collaboration
Collaborators:
amfAR, The Foundation for AIDS Research Chulalongkorn University PHPT/AMS Laboratory, Faculty of Associated Medical Sciences, Chiang Mai University Radboud University ViiV Healthcare